Science Ltd

Edit

Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) (Accustem Sciences Ltd)

Public Technologies 15 May 2026

). Management's Discussion and Analysis of Financial Condition and Results of Operations ... Our actual results could differ materially from those discussed in the forward-looking statements ... Forward-Looking Statements ... Overview ... Accustem Sciences Ltd.

Edit

SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Developing Distinct Next-Gen GLP-1 Built Around Novel Peptide

Nasdaq Globe Newswire 14 May 2026

Disseminated on behalf of�SureNano Science Ltd. (CSE. SURE) (OTCQB. SURNF)�and may include paid advertising ... .

Edit

Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab (Form 6-K) (Tiziana Life Sciences Ltd)

Public Technologies 14 May 2026

BOSTON, MA, May 14, 2026 - Tiziana Life Sciences, Ltd ... foralumab," said Ivor Elrifi, Chief Executive Officer of Tiziana Life Sciences ... About Tiziana Life Sciences ... Tiziana Life Sciences Ltd.

Edit

Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference (Wave Life Sciences Ltd)

Public Technologies 13 May 2026

CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd ... A live webcast of the presentation can be accessed by visiting "Investor Events" on the Investors section of the Wave Life Sciences website ... Wave Life Sciences Ltd.

Edit

SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advancing a Differentiated Next-Gen GLP-1 Platform

Enid News & Eagle 12 May 2026

Disseminated on behalf of SureNano Science Ltd. (CSE. SURE) (OTCQB. SURNF) and may include paid advertising ... .

Edit

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provide Business Update on Wednesday, May 20, 2026 (Roivant Sciences Ltd)

Public Technologies 12 May 2026

). BASEL, Switzerland and LONDON and NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq. ROIV) today announced that it will host a live conference call and webcast at 8.00 a.m ... About Roivant Roivant (Nasdaq ... Contacts . ... Media ... Roivant Sciences Ltd.

Edit

Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York

ACCESSWIRE 07 May 2026

VANCOUVER, BC / ACCESS Newswire / May 6, 2026 / Lobe Sciences Ltd ... Frederick D. Sancilio, will be attending the D. Boral Capital Global Conference being held on May 7, 2026 at The Plaza Hotel in New York City. Dr ... Dr ... Lobe Sciences Ltd ... Lobe Sciences Ltd.

Edit

Proxy Statement (Form DEF 14A) (Wave Life Sciences Ltd)

Public Technologies 07 May 2026

WAVE LIFE SCIENCES LTD ... Dear Shareholders of Wave Life Sciences Ltd... We are making this proxy statement available in connection with the solicitation by the board of directors of Wave Life Sciences Ltd ... WAVE LIFE SCIENCES LTD ... WAVE LIFE SCIENCES LTD.

Edit

Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for

Hastings Tribune 01 May 2026

Novel dual-mechanism anti-IgE antibody designed to improve upon existing and emerging therapies for IgE-mediated diseases ... .

Edit